Skip to main content

People in the News: Jan 18, 2011


Saladaz Biomedical has named Edward Erickson as its new president and CEO. Prior to joining Saladax, Erickson was president and CEO of BioNanomatrix. Before that, he was chairman, president, and CEO of Cellatope. He held similar roles at Immunicon, DepoTech, and Cholestech.

Erickson is currently a director of BioNanomatrix, Metabolon, and MDxHealth. He holds an MBA from the Harvard Graduate School of Business Administration and BS and MS degrees from the Illinois Institute of Technology.

Sequenom has appointed William Welch to be senior vice president of diagnostics, a role in which he will be responsible for all commercial aspects of the firm’s diagnostics business. Welch formerly was senior VP and chief commercial officer at Monogram Biosciences, VP of sales and marketing at La Jolla Pharmaceuticals, and he worked in general management at Abbott Laboratories.

Agilent Technologies has named Tachi Yamada to its board of directors. Yamada currently serves as president of the global health program of the Bill & Melinda Gates Foundation. Previously, he was chairman of research and development at GlaxoSmithKline.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.